TARSUS PHARMACEUTICALS, INC.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $562.2M
Liabilities Breakdown FY2025
Total Liabilities: $218.7M
Asset Breakdown
Total Assets: $562.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $183.6M | 32.7% |
| Accounts Receivable | $85.1M | 15.1% |
| Inventory | $4.4M | 0.8% |
| Property, Plant & Equipment | $11.7M | 2.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $7.4M | 1.3% |
| Other Assets | $270.1M | 48.0% |
Liabilities Breakdown
Total Liabilities: $218.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $16.4M | 7.5% |
| Long-Term Debt | $72.4M | 33.1% |
| Other Liabilities | $129.9M | 59.4% |